2024-07-25 12:35:09 ET
NovoCure Limited [NVCR]
Q2 2024 Earnings Conference Call
July 25, 2024, 8:00 a.m. ET
Company Participants
Bill Doyle - Executive Chairman
Asaf Danziger - CEO
Ashley Cordova - CFO
Frank Leonard - EVP and President of NovoCure Oncology
Nicolas Leupin - Chief Medical Officer
Ingrid Goldberg - Investor Relations
Conference Call Participants
Jonathan Chang - Leerink Partners
Jason Bednar - Piper Sandler
Larry Biegelsen - Wells Fargo
Jessica Fye - J.P. Morgan
Vijay Kumar - Evercore ISI
Emily Bodnar - H.C. Wainwright
Presentation
Operator
Good day and thank you for standing by. Welcome to the NovoCure Q2 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, Ingrid Goldberg. Please go ahead.
Ingrid Goldberg
Good morning, and thank you for joining us to review NovoCure's second quarter 2024 performance. I am joined this morning by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team will be available for Q&A. For your reference, slides accompanying this earnings release can be found on our website, www.NovoCure.com and on our Investor Relations page under Quarterly Reports....
Read the full article on Seeking Alpha
For further details see:
NovoCure Limited (NVCR) Q2 2024 Earnings Call Transcript